AZ vaccine vaccination is being reviewed in the 2nd quarter

By Kim, Jung-Ju | translator Choi HeeYoung

21.04.27 14:55:09

가나다라 0

The KCDA Commissioner Jung Eun-kyeong mentioned at the Central Disease Control Headquarters briefing

It was decided to strengthen guidance on encouraging vaccinations such as health care professionals

The quarantine authorities are considering expanding the age range for AstraZeneca COVID-19 vaccine. Although it is currently impossible to select a product, it will be reviewed after sufficiently diversifying the quantity while changing the inoculation institution for each product characteristic in the future.
Thr KCDA Commissioner Jeong Eun-kyung responded in this way during the inquiry time for the COVID-19 Central Disease Control Headquarters Regular Briefing' during the day on the 26th.

The quarantine authorities are considering expanding the possibility of a second quarter vaccination plan. The authorities currently supply 3.87 million doses of AstraZeneca and Pfizer vaccines, and are expec

Kim, Jung-Ju(jj0831@dailypharm.com)

If you want to see the full article, please JOIN US (click)